Evidence map›Paper›PMID 35915312›Full record

ArticleScientific reports2022

The interplay between cognition, depression, anxiety, and sleep in primary Sjogren's syndrome patients.

Radjiv Goulabchand, Elodie Castille, Sophie Navucet, Damien Etchecopar-Etchart, Aurélie Matos, Alexandre Maria, Laure Anne Gutierrez, Alain Le Quellec, Nicolas Menjot de Champfleur, Audrey Gabelle and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Observational
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Radjiv Goulabchand *Internal Medicine Department, CHU Nîmes, Place du Pr Debre, 30029, Nîmes Cedex, France. radjiv.goulabchand@chu-nimes.fr.
Elodie Castille *University of Montpellier, Montpellier, France.
Sophie NavucetDepartment of Neurology, Memory Research and Resources Alzheimer Center, Gui de Chauliac Hospital, Montpellier University Hospital, Montpellier, France.
Damien Etchecopar-EtchartFaculté de Médecine-Secteur Timone, EA 3279: CEReSS-Centre d'Etude et de Recherche sur les Services de Santé et la Qualité de vie, Aix-Marseille Université, Marseille, France.
Aurélie MatosDepartment of Neurology, Memory Research and Resources Alzheimer Center, Gui de Chauliac Hospital, Montpellier University Hospital, Montpellier, France.
Alexandre MariaUniversity of Montpellier, Montpellier, France.
Laure Anne GutierrezUniversity of Montpellier, Montpellier, France.
Alain Le QuellecUniversity of Montpellier, Montpellier, France.
Nicolas Menjot de ChampfleurDepartment of Neuroradiology, I2FH, Institut d'Imagerie Fonctionnelle Humaine, Gui de Chauliac Hospital, Montpellier University Hospital, Montpellier, France.
Audrey Gabelle *University of Montpellier, Montpellier, France.
Philippe Guilpain *University of Montpellier, Montpellier, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary Sjögren's syndrome (pSS) is an autoimmune disease with frequent neurological involvement. Memory complaints are common, but their precise patterns remain unclear. We wanted to characterize patterns of neurocognitive profiles in pSS patients with cognitive complaints. Only pSS patients with memory complaints were included, prospectively. Cognitive profiles were compiled through a comprehensive cognitive evaluation by neuropsychologists. Evaluations of anxiety, depression, fatigue, sleep disorders and quality of life were performed for testing their interactions with cognitive profiles. All 32 pSS patients showed at least borderline cognitive impairment, and 17 (53%) exhibited a pathological cognitive profile: a hippocampal profile (37%), a dysexecutive profile (22%), and an instrumental profile (16%) (possible overlap). Regarding the secondary objectives: 37% of patients were depressed, and 48% exhibited a mild-to-severe anxiety trait. Sleep disorders were frequent (excessive daytime sleepiness (55%), high risk for sleep apnea (45%), and insomnia (77%)). Cognitive impairments could not be explained alone by anxiety, depression or sleep disorders. Fatigue level was strongly associated with sleep disorders. Our study highlights that cognitive complaints in pSS patients are supported by measurable cognitive impairments, apart from frequently associated disorders such as depression, anxiety or sleep troubles. Sleep disorders should be screened.

Indexed as

Sjogren's SyndromeSleep Wake DisordersAnxietyCognitionDepressionFatigueHumansQuality of LifeSleep

Identifiers

PMID35915312
PMCPMC9343365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.